Compugen (Israel) Top Management

CGEN Stock  ILA 595.00  7.20  1.20%   
Compugen employs about 73 people. The company is managed by 23 executives with a total tenure of roughly 175 years, averaging almost 7.0 years of service per executive, having 3.17 employees per reported executive. Analysis of Compugen's management performance can provide insight into the company performance.
Anat CohenDayag  CEO
President, Chief Executive Officer, Director
Paul Sekhri  Chairman
Chairman of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
For information on how to trade Compugen Stock refer to our How to Trade Compugen Stock guide.

Compugen Management Team Effectiveness

The company has return on total asset (ROA) of (0.2301) % which means that it has lost $0.2301 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4394) %, meaning that it generated substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities.
Compugen holds a total of 86.62 Million outstanding shares. Compugen shows 5.5 percent of its outstanding shares held by insiders and 27.56 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Compugen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Compugen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Compugen Workforce Comparison

Compugen is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 2,144. Compugen holds roughly 73.0 in number of employees claiming about 3% of stocks in Biotechnology industry.

Compugen Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Compugen Price Series Summation is a cross summation of Compugen price series and its benchmark/peer.

Compugen Notable Stakeholders

A Compugen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Compugen often face trade-offs trying to please all of them. Compugen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Compugen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Anat CohenDayagPresident, Chief Executive Officer, DirectorProfile
Paul SekhriChairman of the BoardProfile
Zurit LevineVice President - Research and DiscoveryProfile
Ari KrashinChief Financial OfficerProfile
Michal PremingerDirectorProfile
Arie OvadiaIndependent External DirectorProfile
Eran PerryDirectorProfile
Sanford ZweifachDirectorProfile
Gilead HalevyDirectorProfile
Ruth ArnonIndependent DirectorProfile
Kinneret SavitskyDirectorProfile
Yair AharonowitzIndependent External DirectorProfile
JeanPierre BizzariDirectorProfile
John HunterVP of Antibody RandD and Site Head of Compugen USA IncProfile
Alberto SessaChief OfficerProfile
Rivka SchwartzVP DiscoveryProfile
Henry MDVP OfficerProfile
Yvonne NaughtonHead CommunicationsProfile
Henry AdewoyeChief Medical OfficerProfile
Dorit AmitayVP HRProfile
Eran DorGen SecProfile
Oliver FroescheisSr DevelProfile
String symbol = request.getParameter("s");

About Compugen Management Performance

The success or failure of an entity such as Compugen often depends on how effective the management is. Compugen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Compugen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Compugen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people.
Please note, the presentation of Compugen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Compugen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Compugen's management manipulating its earnings.

Compugen Workforce Analysis

Traditionally, organizations such as Compugen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Compugen within its industry.

Compugen Manpower Efficiency

Return on Compugen Manpower

Revenue Per Employee82.2K
Revenue Per Executive260.9K
Net Loss Per Employee468.5K
Net Loss Per Executive1.5M
Working Capital Per Employee1.2M
Working Capital Per Executive3.7M

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk